BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 29, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

PTI-188: Preliminary Phase I data

Top-line data from an open-label, dose-escalation, Israeli Phase I trial in 12 patients with stage III or IV melanoma showed that a single IV...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >